The pharmacokinetics of prednisolone and prednisone in adult liver transplant recipients early after transplantation

Therapeutic Drug Monitoring

Volumn 34, Issue 4, 2012, Pages 452-459

  Sæves, Ingjerd ^a,b   Line, Pål Dag ^a   Bergan, Stein ^b,c  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

11 beta hydroxysteroid dehydrogenase; glucocorticoids; liver transplantation; pharmacokinetics; prednisolone; prednisone; therapeutic drug monitoring; variability

Indexed keywords

METHYLPREDNISOLONE; PREDNISONE;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG HALF LIFE; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER TRANSPLANTATION; MALE; MAXIMUM PLASMA CONCENTRATION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL;

ADULT; AGED; AREA UNDER CURVE; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIVER; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PREDNISOLONE; PREDNISONE; YOUNG ADULT;

EID: 84863827190     PISSN: 01634356     EISSN: 15363694     Source Type: Journal    
DOI: 10.1097/FTD.0b013e31825ee3f8     Document Type: Article

References (28)

1. Czock D, Keller F, Rasche FM, et al. Pharmacokinetics and pharmaco-dynamics of systemically administered glucocorticoids. Clin Pharmacokinet. 2005;44:61-98. (Pubitemid 40096038)
2. Lewis JG, Bagley CJ, Elder PA, et al. Plasma free cortisol fraction reflects levels of functioning corticosteroid-binding globulin. Clin Chim Acta. 2005;359:189-194. (Pubitemid 41116312)
3. Amelung D, Hubener HJ, Roka L, et al. Conversion of cortisone to compound F. J Clin Endocrinol Metab. 1953;13:1125-1126.
4. Diederich S, Eigendorff E, Burkhardt P, et al. 11beta-hydroxysteroid dehydrogenase types 1 and 2: an important pharmacokinetic determinant for the activity of synthetic mineralo- and glucocorticoids. J Clin Endocrinol Metab. 2002;87:5695-5701. (Pubitemid 36034378)
5. Ricketts ML, Verhaeg JM, Bujalska I, et al. Immunohistochemical localization of type 1 11beta-hydroxysteroid dehydrogenase in human tissues. J Clin Endocrinol Metab. 1998;83:1325-1335. (Pubitemid 28496416)
6. Tomlinson JW, Walker EA, Bujalska IJ, et al. 11Beta-hydroxysteroid dehydrogenase type 1: a tissue-specific regulator of glucocorticoid response. Endocr Rev. 2004;25:831-866. (Pubitemid 39366049)
7. Edwards CR, Stewart PM, Burt D, et al. Localisation of 11 beta-hydroxysteroid dehydrogenase-tissue specific protector of the mineralocorticoid receptor. Lancet. 1988;2:986-989.
8. Osinski PA. Steroid 11beta-ol dehydrogenase in human placenta. Nature. 1960;187:777.
9. Roland BL, Funder JW. Localization of 11beta-hydroxysteroid dehydrogenase type 2 in rat tissues: in situ studies. Endocrinology. 1996;137:1123-1128.
10. Stewart PM. 11 beta-Hydroxysteroid dehydrogenase: implications for clinical medicine. Clin Endocrinol (Oxf). 1996;44:493-499. (Pubitemid 26168766)
11. Whorwood CB, Ricketts ML, Stewart PM. Epithelial cell localization of type 2 11 beta-hydroxysteroid dehydrogenase in rat and human colon. Endocrinology. 1994;135:2533-2541. (Pubitemid 24377413)
12. Pichard L, Fabre I, Daujat M, et al. Effect of corticosteroids on the expression of cytochromes P450 and on cyclosporin A oxidase activity in primary cultures of human hepatocytes. Mol Pharmacol. 1992;41:1047-1055. (Pubitemid 23026103)
13. Schuetz EG, Furuya KN, Schuetz JD. Interindividual variation in expression of P-glycoprotein in normal human liver and secondary hepatic neoplasms. J Pharmacol Exp Ther. 1995;275:1011-1018. (Pubitemid 26023635)
14. Ueda K, Okamura N, Hirai M, et al. Human P-glycoprotein transports cortisol, aldosterone, and dexamethasone, but not progesterone. J Biol Chem. 1992;267:24248-24252.
15. Green OC, Winter RJ, Kawahara FS, et al. Plasma levels, half-life values, and correlation with physiologic assays for growth and immunity. J Pediatr. 1978;93:299-303.
16. Knight SR, Morris PJ. Steroid avoidance or withdrawal after renal transplantation increases the risk of acute rejection but decreases cardiovascular risk. A meta-analysis. Transplantation. 2010;89:1-14.
17. Knight SR, Morris PJ. Steroid sparing protocols following nonrenal transplants; the evidence is not there. A systematic review and meta-analysis. Transpl Int. 2011;24:1198-1207.
18. Saeves I, Vethe NT, Bergan S. Quantification of 6 glucocorticoids in human plasma by liquid chromatography tandem mass spectrometry: method development, validation, and assessment of matrix effects. Ther Drug Monit. 2011;33:402-410.
19. Bauer AJ, Boeckxstaens GE. Mechanisms of postoperative ileus. Neurogastroenterol Motil. 2004;16(suppl 2):54-60. (Pubitemid 39468867)
20. Wallden J, Thorn SE, Lovqvist A, et al. The effect of anesthetic technique on early postoperative gastric emptying: comparison of propofolremifentanil and opioid-free sevoflurane anesthesia. J Anesth. 2006;20:261-267. (Pubitemid 44650706)
21. Boudinot FD, Jusko WJ. Plasma protein binding interaction of prednisone and prednisolone. J Steroid Biochem. 1984;21:337-339. (Pubitemid 15224235)
22. Potter JM, McWhinney BC, Sampson L, et al. Area-under-the-curve monitoring of prednisolone for dose optimization in a stable renal transplant population. Ther Drug Monit. 2004;26:408-414. (Pubitemid 38989660)
23. Gambertoglio JG, Vincenti F, Feduska NJ, et al. Prednisolone disposition in cushingoid and noncushingoid kidney transplant patients. J Clin Endocrinol Metab. 1980;51:561-565. (Pubitemid 10022841)
24. Seidegard J, Simonsson M, Edsbacker S. Effect of an oral contraceptive on the plasma levels of budesonide and prednisolone and the influence on plasma cortisol. Clin Pharmacol Ther. 2000;67:373-381. (Pubitemid 30246814)
25. Zhang J, Kuehl P, Green ED, et al. The human pregnane X receptor: genomic structure and identification and functional characterization of natural allelic variants. Pharmacogenetics. 2001;11:555-572. (Pubitemid 32953582)
26. Miura M, Satoh S, Inoue K, et al. Influence of CYP3A5, ABCB1 and NR1I2 polymorphisms on prednisolone pharmacokinetics in renal transplant recipients. Steroids. 2008;73:1052-1059.
27. Miura M, Inoue K, Kagaya H, et al. Inter-individual difference determinant of prednisolone pharmacokinetics for Japanese renal transplant recipients in the maintenance stage. Xenobiotica. 2009;39:939-945.
28. Azimzadeh AM, Lees JR, Ding Y, et al. Immunobiology of transplantation: impact on targets for large and small molecules. Clin Pharmacol Ther. 2011;90:229-242.